Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

Bonn 53127

0 studies enrolling now · 1 studies all time

What they study most

Amyotrophic Lateral Sclerosis

Studies at this site

• A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS) — Completed